Anticoagulation for Dentistry Flashcards

1
Q

Thrombosis
Types
Characteristics

A
Inappropriate blood coagulation within a vessel 
Arterial
Fast flowing
high pressure 
platelet rich

Venous
involves coagulation cascade
low pressure
fibrin rich

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Appropriate blood coagulation occurs when

Failure

A

blood escapes from vessel

bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Thrombosis treatment
Arterial
Venous

A

Anti platelet drugs

Anticoagulant drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Guidelines

A
Scottish Dental Clinical Effectiveness guideline 
Evidence based
Up to date 
Freely available 
Printed advice for patients 
DOAC guideline less cautious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anti platelet drugs - aspirin

A

Inhibits COX irreversibly
Acts for lifetime of platelet i.e 7-10 days
75-300mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anti platelet drugs - clopidogrel

A

Blocks ADP receptor (on platelet surface) irreversibly
Acts for lifetime of platelet i.e. 7-10 days
75mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anti platelet drugs - prasugrel

A

Blocks ADP receptor
irreversibly
blocks ALL platelets
Acts for lifetime of platelet i.e. 7-10 days
More rapid and consistent inhibition than clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anti platelet drugs and dental procedures

A

Balance risk of bleeding vs risk of thrombosis

Anti platelet medications do not have be stopped during PRIMARY care dental procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anticoagulant drugs

A

Intravenous
Subcutaneous
Oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anticoagulant drugs - IV

A

Unfractionated heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anticoagulant drugs - subcutaneous

A

Low molecular weight heparins e.g enoxaparin, tinzaparin, dalteparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anticoagulant drugs - oral

A

Warfarin, dabigatran, rivaroxaban, apixoban, edoxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Heparin 
Source
Mechanism? 
Delivery 
Who to
Monitored with?
A

Glycosaminoglycan from porcine mucosa

Binds to antithrombin and increases activity
Indirection thrombin inhibitor (as acts by enhancing activity of antithrombin)

Continuous infusion
Hospital patients
APTT test
Ratio of 1.8-2.8 desired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Low molecular weight heparin

structure?
Delivery
Excretion and frequency of delivery

Used for

Timings

A
Smaller molecule from unfractionated heparin 
SC
Really excreted
given once daily 
no monitoring 

Treatment and prophylaxis
Give last dose 24 hours before dental surgery
Half life of 12 hrs
Next dose 4 hrs after dental surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Warfarin - pharmacology
Delivery
Bound to
Mechanism?

A

Given orally
99% plasma protein bound
Inhibits production of factors II, VII, IX, X and protein C and S

Metabolised by liver (cytochrome P450)

Has peak effect 3-4 days after start - residual factors have to be used up
Effect still present 4- days after stopping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Warfarin interactions

A

Potentiation of anticoagulation

Inhibition of anticoagulation

17
Q

Warfarin - Potentiation of anticoagulation

A

Reduced warfarin binding to albumin e.g by phenytoin

Inhibition of hepatic microsomal degradation of warfarin e.g by erythromycin

18
Q

Warfarin interactions - inhibition of anticoagulation

A

Acceleration of hepatic microsomal degradation of warfarin e.g by carbamazepine
Enhanced synthesis of clotting factors e.g by vitamin K

19
Q

Warfarin monitoring
Test
Dose based on
FREQUENCY DEPENDS ON

A

International normalised ratio
INR
Stability of INR e.g 1/week 1-8 weeks
Must be measured before surgery or invasive procedures
Measured using near patient testing device
Uses drop of blood

20
Q

Anticoag INR targets

A

INR 2-3 - treatment of DVT , atrial fibrillation - 2 = 2x long for blood to clot
INR 3-4.5 e.g recurrent DVT on warfarin
Mechanical heart valves

21
Q

Warfarin side effects

Annual risk

A
3% bleeding 
1% serious
0.3% death due to bleeding 
Skin necrosis 
Embryopathy
22
Q

Warfarin reversal options

A

Stop warfarin
Vitamin K - IV preparation, 80% correction
Fresh frozen plasma - large vole
Clotting factor concentrate -

23
Q

Clotting factor concentrate -

A

Factors II, VII, IX, X - IN 10 MINS

24
Q

Warfarin warnings

A
No IM injections 
No aspirin, NSAID without consultation 
No contact sports m
moderate alcohol
signify changes in diet
25
Q

Dental extractions and warfarin

A

Lower risk nowadays of thrombotic episode

26
Q

Safe to perform X-LA on warfarin when

Metal heart valve patients will

A

INR < 4.0

Remain on warfarin

27
Q

New non warfarin oral anticoagulants

A

NOACS -new oral anticoagulants

DOACS

28
Q

RIVAROXABAN, PIXABAN, ADOXABAN

DABIGATRAN A

A

Inhibit Fx Xa
inhibits thrombin factor ii

may replace low molecular weight heparin for prophylaxis
also treats thrombosis and AF

29
Q

DOACs

A
Prevention and treatment of thrombosis 
Replacing warfarin 
No monitoring 
No alcohol/food interactions 
Half life 6-15
 hrs 
Dabigattran is mainly recalled excreted
30
Q

DOACs in dental surgery

A

Use vasoconstrictor in LA
Use infiltration if poss
Delay work until discontinuation if short term
Do not take anticoag on morning of work Restart 4hrs post procedure

31
Q

APIXABAN/DABIGATRAN

A

2x a day
Miss morning dose pre treatment
Given at usual time in evening

32
Q

Rivaroxaban

A

once a day
delay morning dose pre treatment for later effect
resume 4hrs after haemostasis
Partially really excreted

33
Q

Edoxaban

A

Once a day - evening
Doesn’t need to delay in morning
Resume at usual time